144 filed Oct 15, 2026 at 09:41 ET
Medtronic CEO Geoffrey Martha filed a Form 144 notice of intent to sell 50,000 shares of common stock, with an estimated aggregate market value of approximately $4.75 million based on a filing price of $95.00 per share. The shares were acquired through restricted stock vesting and a stock option exercise dating back to 2018–2025, and the sale is planned through Fidelity Brokerage Services. While the dollar amount is modest relative to Martha's total holdings and Medtronic's market cap, a CEO sale ahead of the next earnings cycle warrants monitoring.